Healthcare -
Biotechnology - NASDAQ - US
$ 15.5
-6.4 %
$ 2.25 B
Market Cap
-6.03
P/E
DNLI - GROSS PROFIT
Gross Profit DNLI - Denali Therapeutics Inc.
314 M
LAST VALUE
169.98%
2 YEAR CAGR
20.85%
5 YEAR CAGR
0.00%
10 YEAR CAGR